Jeff Fairman - 02 Sep 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Signature
Jeff Fairman, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
02 Sep 2022
Net transactions value
-$146,583
Form type
4
Filing time
07 Sep 2022, 16:37:31 UTC
Previous filing
05 Aug 2022
Next filing
13 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability $13,691 -519 -2.9% $26.38 17,143 02 Sep 2022 Direct F1
transaction PCVX Common Stock Sale $123,774 -4,664 -1.5% $26.54 301,563 06 Sep 2022 By Fairman Family Trust F2, F3
transaction PCVX Common Stock Sale $9,118 -336 -0.11% $27.14 301,227 06 Sep 2022 By Fairman Family Trust F2, F4
holding PCVX Common Stock 50,000 02 Sep 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F2 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported is a weighted-average price. The shares were sold at prices ranging from $26.04 to $27.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The price reported is a weighted-average price. The shares were sold at prices ranging from $27.09 to $27.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.